Skip to main content
. 2022 Jul 10;10(4):e00985. doi: 10.1002/prp2.985

TABLE 2.

Hypersensitivity reactions with and without use of ranitidine as premedication for paclitaxel

Number of: Total Ranitidine No ranitidine p‐value
Patients 108 45 63
Administrations 836 349 487
Hypersensitivity reactions per administration 20 (2.4%) 8 (2.3%) 12 (2.5%) .87
Patients with hypersensitivity reactions 18 (16.7%) 8 (17.8%) 10 (15.8%) .80